Human Cancer Biology Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma

Abstract

Purpose: Lung adenocarcinoma and lung squamous cell carcinoma (SCC) are the most common non–small cell lung cancer (NSCLC) subtypes. This study was designed to determine whether reduced expression of TGFb type II receptor (TGFbRII) promotes lung adenocarcinoma and SCC

6 Figures and Tables

Cite this paper

@inproceedings{Malkoski2012HumanCB, title={Human Cancer Biology Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma}, author={Stephen P. Malkoski and Sarah M. Haeger and T. G. Cleaver and Karen J. Rodriguez and Howard Li and Shi-Long Lu and William J. Feser and Anna E. Bar and Daniel T. Merrick and Jessyka G. Lighthall and Hideaki Ijichi and Xiao-Jing Wang}, year={2012} }